| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 05/20/1999 | CA2276250A1 Ciita-interacting proteins and methods of use therefor |
| 05/19/1999 | EP0915977A1 B. burgdorferi polypeptides expressed in vivo |
| 05/19/1999 | EP0915974A1 Modified tie-2-receptor ligands |
| 05/19/1999 | EP0915970A1 Type c lectins |
| 05/18/1999 | CA1340547C Novel secretory leader sequences for yeasts |
| 05/18/1999 | CA1340542C Molecular cloning and characterization of a gene sequence coding for human relaxin |
| 05/14/1999 | WO1999023236A1 Method of dna shuffling |
| 05/14/1999 | WO1999023221A2 Multivalent antigen-binding proteins |
| 05/14/1999 | WO1999023116A1 ASSAY EMPLOYING CadC FUSION PROTEINS |
| 05/14/1999 | WO1999023112A1 A FUSION PROTEIN OF hEGF AND HUMAN ANGIOGENIN, AND PROCESS FOR PREPARING THE SAME |
| 05/14/1999 | WO1999022761A1 Conjugate heat shock protein-binding peptides |
| 05/14/1999 | WO1999011282A9 Compositions and methods for contraception in or sterilization of mammals |
| 05/14/1999 | WO1999003508A9 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 05/14/1999 | CA2308299A1 Conjugate heat shock protein-binding peptides |
| 05/12/1999 | EP0914614A1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrP?c AND PrP?sc |
| 05/12/1999 | EP0914453A1 HUMAN INTERLEUKIN-1j AND ANTAGONISTS THEREOF |
| 05/12/1999 | EP0914435A1 Hybrid interferon compositions and methods of use |
| 05/12/1999 | EP0914346A1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FC$g(a) RECEPTOR ANTIBODIES |
| 05/12/1999 | EP0914339A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 05/12/1999 | CN1043350C Method for preparation of cardiac muscle cell growth stimulus peptide |
| 05/11/1999 | CA2127362C Expression and purification of recombinant soluble tissue factor |
| 05/11/1999 | CA2124085C Receptor for oncostatin m and leukemia inhibitory factor |
| 05/11/1999 | CA2122724C Fusion proteins comprising mgf and il-3 |
| 05/06/1999 | WO1999021999A2 Wnt-1 inducible genes |
| 05/06/1999 | WO1999021998A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3 |
| 05/06/1999 | WO1999021572A1 Soluble mhc complexes and methods of use thereof |
| 05/06/1999 | EP0913691A1 Site-specific conjugation of glycoproteins |
| 05/06/1999 | EP0912758A1 Compositions and methods for screening antimicrobials |
| 05/06/1999 | EP0912734A1 Chimeric heteromultimer adhesins |
| 05/06/1999 | EP0912730A2 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 05/06/1999 | EP0742721B1 Methods of prolonged suppression of humoral immunity |
| 05/06/1999 | EP0589004B1 Process for the determination of peptides corresponding to immunologically important epitopes of hcv |
| 05/06/1999 | CA2307178A1 Soluble mhc complexes and methods of use thereof |
| 05/06/1999 | CA2306183A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3 |
| 05/04/1999 | US5900476 Mutant polypeptide without cysteines, or modified to prevent disulfide bond formation suppresses binding of factor to platelets; antithrombosis agents |
| 05/04/1999 | CA2037333C Dna encoding a major mite allergen and the use thereof |
| 05/04/1999 | CA1340525C Immunoassay for the detection of a-haloacetamides |
| 05/04/1999 | CA1340522C Fusion proteins containing neighbouring histidines for improved purification |
| 04/29/1999 | WO1999020762A1 Icam-6 materials and methods |
| 04/29/1999 | WO1999020756A2 Human toll homologues |
| 04/29/1999 | WO1999020653A1 Low-toxicity human interferon-alpha analog |
| 04/29/1999 | WO1999006551A3 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
| 04/29/1999 | CA2305385A1 Human toll homologues |
| 04/28/1999 | EP0911399A2 A kringle-related clone, HTHBZ47 |
| 04/28/1999 | EP0910654A1 Enzyme combinations for destroying proliferative cells |
| 04/28/1999 | EP0910648A1 Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods |
| 04/28/1999 | EP0910571A2 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis |
| 04/28/1999 | EP0723555A4 Chimeric proteins which block complement activation |
| 04/28/1999 | EP0592480B1 Use of papillomavirus L2 protein for therapeutic treatment of papillomavirus tumours or lesions |
| 04/27/1999 | CA2107329C Anti-human immunodeficiency virus recombinant antibodies |
| 04/22/1999 | WO1999019484A1 T cell receptor-associated molecules (trams) and methods of use therefor |
| 04/22/1999 | WO1999019470A2 Gfp-annexin fusion proteins |
| 04/22/1999 | WO1999006577A3 Agent for expressing and detecting a fusion polypeptide with an hpol-epitope and a polypeptide |
| 04/22/1999 | WO1998053068A9 Smad7 and uses thereof |
| 04/22/1999 | WO1998048837A9 Polyalkylene oxide-modified single chain polypeptides |
| 04/22/1999 | WO1998047921A9 Mammalian cytokines; related reagents and methods |
| 04/21/1999 | EP0909324A2 Toxins active against pests |
| 04/21/1999 | EP0640131B1 Genetically engineered antibodies |
| 04/21/1999 | CN1214694A Peptides with antiproliferative properties |
| 04/20/1999 | CA1340506C Production of gonorrheal pi proteins and vaccines |
| 04/14/1999 | EP0907886A1 Retinoid x receptors and components of the basal transcription machinery |
| 04/14/1999 | EP0907733A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 04/14/1999 | EP0907730A1 Haemopoietin receptor and genetic sequences encoding same |
| 04/14/1999 | EP0907661A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF alpha v beta 5 MEDIATED ANGIOGENESIS |
| 04/14/1999 | EP0907659A1 Synthetic inhibitors of hepatitis c virus ns3 protease |
| 04/14/1999 | EP0725793A4 Protease-derivatized cvf |
| 04/14/1999 | EP0643559B1 Diphtheria toxin receptor-binding region |
| 04/14/1999 | CN1214052A Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 04/13/1999 | CA2079584C Methods for trans-destabilization of specific proteins in vivo |
| 04/08/1999 | WO1999016894A1 Method for determining active agents |
| 04/08/1999 | WO1999016710A1 Immunogenic conjugated polypeptide for treatment of herpes simplex virus |
| 04/08/1999 | WO1999006549A3 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES |
| 04/08/1999 | WO1999006439A3 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM |
| 04/08/1999 | WO1999003987A3 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 04/08/1999 | WO1999003508A3 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 04/08/1999 | WO1998058053A9 Human receptor tyrosine kinase, kdr |
| 04/08/1999 | CA2304665A1 Immunogenic conjugated polypeptide for treatment of herpes simplex virus |
| 04/07/1999 | EP0754227A4 Chimeric complement inhibitor proteins |
| 04/07/1999 | EP0642579B1 Improved methods for the preparation of endotoxin-binding proteins |
| 04/07/1999 | CN1213403A Polypeptides having mutanase activity and nucleic acids encoding same |
| 04/07/1999 | CN1213380A Peptide immunogens for vaccination against and treatment of allergy |
| 04/06/1999 | US5892020 Multivalent single chain antibodies |
| 04/06/1999 | US5891996 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use |
| 04/06/1999 | US5891991 Aplp1 and aplp2 are candidate genes for late onset familial alzheimer's disease. |
| 04/06/1999 | US5891706 Hybridoma cell line; therapy and diagnosis of autoimmune skin disorders, antitumor agents |
| 04/06/1999 | US5891680 Dna molecule encoding an active il-12 fusion protein with at least two polypeptide monomers linked by heterologous polypeptide linker; stimulates ifn-alpha production, enhances antitumor immunity and cell mediated immunity |
| 04/06/1999 | US5891671 Method for cleaving chimeric protein using processing enzyme |
| 04/06/1999 | US5891640 Peptide derived from human immunodeficiency virus type 1 (HIV-1), isolate ant70, containing an immunodominant epitope and it's use in immunodiagnostic assays |
| 04/06/1999 | CA2095836C Cytokine immunoconjugates |
| 04/01/1999 | WO1999015671A1 Hepatitis b virus polypeptides |
| 04/01/1999 | WO1999015664A1 Insulin-like polypeptide and uses therefor |
| 04/01/1999 | WO1999015653A2 Tie ligand homologues |
| 04/01/1999 | WO1999002708A8 Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein |
| 04/01/1999 | WO1998055615A9 Apaf-1, the ced-4 human homolog, an activator of caspase-3 |
| 04/01/1999 | WO1998053075A3 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 04/01/1999 | WO1998039363A3 Immunotoxins and methods of inducing immune tolerance |
| 04/01/1999 | CA2304129A1 Tie ligand homologues |
| 04/01/1999 | CA2304102A1 Insulin-like polypeptide and uses therefor |
| 04/01/1999 | CA2246004A1 A kringle-related clone, hthbz47 |
| 03/31/1999 | EP0905246A1 Cloning of chicken anaemia DNA |